| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.56 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |